StockNews.AI
APYX
StockNews.AI
117 days

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

1. APYX to release Q1 2025 financial results on May 8. 2. Conference call scheduled for 8:00 a.m. ET to discuss results. 3. Renuvion and J-Plasma supported by over 90 clinical publications. 4. APYX focuses on advanced energy technology in medical devices. 5. Company engaged with OEM agreements to broaden its market reach.

4m saved
Insight
Article

FAQ

Why Bullish?

The upcoming earnings report may boost investor confidence, similar to past positive earnings releases.

How important is it?

Earnings reports significantly influence stock prices; upcoming webcast could attract investor interest.

Why Short Term?

Immediate market reactions expected around Q1 earnings; previously strong quarterly performance influenced short-term spikes.

Related Companies

MDIHIIQSENSCDMO
April 24, 2025 08:45 ET  | Source: Apyx Medical Corporation CLEARWATER, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the first quarter of fiscal year 2025 will be released before markets open on Thursday, May 8th. Management will host a conference call at 8:00 a.m. Eastern Time on Thursday, May 8th to discuss the results of the quarter, and to host a question-and-answer session. To listen to the call by phone, interested parties may dial 800-717-1738 (or 646-307-1865 for international callers) and provide access code 63341. Participants should ask for the “Apyx Medical Corporation Call”. A live webcast of the call will be accessible via the following link: Apyx Medical Earnings Webcast and via the Investor Relations section of the Company’s website, where it will be archived for future reference. Investor Relations Contact:Jeremy Feffer Managing Director LifeSci AdvisorsOP: 212-915-2568jfeffer@lifesciadvisors.com About Apyx Medical Corporation:Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical publications. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com

Related News